Cardinal Health (CAH) Stock Forecast & Price Target
CAH Analyst Ratings
Strong Buy
11Buy2Hold0Sell
Based on 13 analysts giving stock ratings to Cardinal Health in the past 3 months
CAH Stock 12 Month Forecast
Average Price Target
MXN 5,242.95▲(12.24% Upside)Based on 13 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is MXN 5,242.95 with a high forecast of MXN 5,570.24 and a low forecast of MXN 4,909.37. The average price target represents a 12.24% change from the last price of MXN 4,671.00.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 5.57K
AverageMXN 5.24K
LowMXN 4.91K
Highest Price TargetHighestMXN 5,570.24Average Price TargetMXN 5,242.95Lowest Price TargetLowestMXN 4,909.37
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Erin Wright | Morgan Stanley | MXN 5,003.78→MXN 5,400.30 | buy | 15.61%Upside | Assigned | 10/30/26 | ||
| Glen Santangelo | Barclays | MXN 5,192.60 | buy | 11.17%Upside | Reiterated | 10/27/26 | ||
| Steven Valiquette | Mizuho Securities | MXN 4,720.54→MXN 5,287.01 | buy | 13.19%Upside | Reiterated | 10/20/26 | ||
| Kevin Caliendo | UBS | MXN 5,287.01→MXN 5,570.24 | buy | 19.25%Upside | Reiterated | 10/16/26 | ||
| Ryan Halsted | RBC Capital | MXN 5,211.48 | buy | 11.57%Upside | Reiterated | 10/12/26 | ||
| Stephen Baxter | Wells Fargo | MXN 5,230.36 | buy | 11.98%Upside | Reiterated | 09/09/26 | ||
| Lisa Gill | J.P. Morgan | MXN 4,909.37 | hold | 5.10%Upside | Reiterated | 08/17/26 | ||
| Charles Rhyee | TD Cowen | MXN 5,192.60→MXN 5,287.01 | buy | 13.19%Upside | Assigned | 08/13/26 | ||
| George Hill | Deutsche Bank | MXN 4,210.73→MXN 4,928.25 | hold | 5.51%Upside | Reiterated | 08/13/26 | ||
| Daniel Grosslight | Citi | MXN 5,003.78→MXN 5,287.01 | buy | 13.19%Upside | Reiterated | 08/12/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | MXN 5,098.19 | buy | 9.15%Upside | Reiterated | 08/12/26 | ||
| Ryan Daniels | William Blair | ― | buy | ― | Reiterated | 08/11/26 | ||
| Michael Cherny | Leerink Partners | MXN 5,192.60→MXN 5,513.60 | buy | 18.04%Upside | Reiterated | 08/11/26 | ||
| Allen Lutz | Bank of America Securities | MXN 4,909.37 | buy | 5.10%Upside | Reiterated | 07/20/26 | ||
 Unknown AnalystNot Ranked | William O'Neil | ― | buy | ― | Initiated | 06/12/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Erin Wright | 10/30/26 | MXN 5,003.78→MXN 5,400.30 | buy | 15.61%Upside | Assigned | Morgan Stanley | ||
| Glen Santangelo | 10/27/26 | MXN 5,192.60 | buy | 11.17%Upside | Reiterated | Barclays | ||
| Steven Valiquette | 10/20/26 | MXN 4,720.54→MXN 5,287.01 | buy | 13.19%Upside | Reiterated | Mizuho Securities | ||
| Kevin Caliendo | 10/16/26 | MXN 5,287.01→MXN 5,570.24 | buy | 19.25%Upside | Reiterated | UBS | ||
| Ryan Halsted | 10/12/26 | MXN 5,211.48 | buy | 11.57%Upside | Reiterated | RBC Capital | ||
| Stephen Baxter | 09/09/26 | MXN 5,230.36 | buy | 11.98%Upside | Reiterated | Wells Fargo | ||
| Lisa Gill | 08/17/26 | MXN 4,909.37 | hold | 5.10%Upside | Reiterated | J.P. Morgan | ||
| Charles Rhyee | 08/13/26 | MXN 5,192.60→MXN 5,287.01 | buy | 13.19%Upside | Assigned | TD Cowen | ||
| George Hill | 08/13/26 | MXN 4,210.73→MXN 4,928.25 | hold | 5.51%Upside | Reiterated | Deutsche Bank | ||
| Daniel Grosslight | 08/12/26 | MXN 5,003.78→MXN 5,287.01 | buy | 13.19%Upside | Reiterated | Citi | ||
| Elizabeth Anderson CFA | 08/12/26 | MXN 5,098.19 | buy | 9.15%Upside | Reiterated | Evercore ISI | ||
| Ryan Daniels | 08/11/26 | ― | buy | ― | Reiterated | William Blair | ||
| Michael Cherny | 08/11/26 | MXN 5,192.60→MXN 5,513.60 | buy | 18.04%Upside | Reiterated | Leerink Partners | ||
| Allen Lutz | 07/20/26 | MXN 4,909.37 | buy | 5.10%Upside | Reiterated | Bank of America Securities | ||
| Unknown AnalystNot Ranked | 06/12/26 | ― | buy | ― | Initiated | William O'Neil |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Cardinal Health
3 Months
Success Rate13/17 ratings generated profit
76%
Average Return
+6.63%
Copying Glen Santangelo's trades and holding each position for 3 Months would result in 76.47% of your transactions generating a profit, with an average return of +6.63% per trade.
1 Year
Success Rate19/20 ratings generated profit
95%
Average Return
+29.16%
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 95.00% of your transactions generating a profit, with an average return of +29.16% per trade.
2 Years
Success Rate26/27 ratings generated profit
96%
Average Return
+68.43%
Copying Eric Coldwell's trades and holding each position for 2 Years would result in 96.30% of your transactions generating a profit, with an average return of +68.43% per trade.
CAH Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 14 | 16 | 20 | 19 | 18 |
| Hold | 1 | 1 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 15 | 17 | 24 | 23 | 22 |
In the current month, CAH has received 18 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. CAH average Analyst price target in the past 3 months is 5,242.95.
CAH Financial Forecast
HighMXN 58.07
ConsensusMXN 55.34
LowMXN 54.12
CAH Earnings Forecast
Next quarter’s earnings estimate for CAH is MXN 55.34 with a range of MXN 54.12 to MXN 58.07. The previous quarter’s EPS was MXN 54.68. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 1.28T
ConsensusMXN 1.25T
LowMXN 1.22T
CAH Sales Forecast
Next quarter’s sales forecast for CAH is MXN 1.25T with a range of MXN 1.22T to MXN 1.28T. The previous quarter’s sales results were MXN 1.20T. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
CAH Stock Forecast FAQ
What is MX:CAH’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is Mex$5,242.95.
What is MX:CAH’s upside potential, based on the analysts’ average price target?
Cardinal Health has 12.24% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cardinal Health a Buy, Sell or Hold?
Cardinal Health has a consensus rating of Strong Buy, which is based on 11 buy ratings, 2 hold ratings and 0 sell ratings.
What is Cardinal Health’s share price target?
The average share price target for Cardinal Health is Mex$5,242.95. This is based on 13 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$5,570.24, and the lowest forecast is Mex$4,909.37. The average share price target represents a 12.24% increase from the current price of Mex$4,671.
What do analysts say about Cardinal Health?
Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Street analysts.
How can I buy shares of Cardinal Health?
To buy shares of MX:CAH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
